Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
Current Medicinal Chemistry. Anti-Cancer Agents|September 28, 2004
Tumor cell resistance to DNA-damaging agents: from apoptosis to neiosisFrançois Martin, Eric Solary
Journal of Leukocyte Biology|January 4, 2014
The emerging specificities of interleukin-34Eric Solary, Nathalie Droin
La Revue Du Praticien|March 24, 2011
[Myeloproliferative/myelodysplastic syndromes]Eric Solary, Michaëla Fontenay
Elife|March 14, 2019
Towards a classification of stem cellsLucie Laplane, Eric Solary
Haematologica|March 25, 2018
Does being overweight contribute to longer survival rates in myelodysplastic syndrome?Eric Solary, Michaela Fontenay
La Revue Du Praticien|March 24, 2011
[Myelodysplastic syndromes]Eric Solary, Michaëla Fontenay
Journal of Leukocyte Biology|May 1, 2010
Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebratesNathalie Droin, Eric Solary
Current Hematologic Malignancy Reports|August 22, 2014
Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practiceDorothée Selimoglu-Buet, Eric Solary
Nature Genetics|March 28, 2008
Re-examining the role of cytochrome c in cell deathEric Solary, Fabrizio Giordanetto, Guido Kroemer
Cancer Discovery|April 4, 2024
Targeting Senescence for Next-Generation Cancer TreatmentsEric Gilson, Pierre Soubeyran, Eric Solary
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
Current Medicinal Chemistry. Anti-Cancer Agents|September 28, 2004
Tumor cell resistance to DNA-damaging agents: from apoptosis to neiosisFrançois Martin, Eric Solary
Journal of Leukocyte Biology|January 4, 2014
The emerging specificities of interleukin-34Eric Solary, Nathalie Droin
La Revue Du Praticien|March 24, 2011
[Myeloproliferative/myelodysplastic syndromes]Eric Solary, Michaëla Fontenay
Elife|March 14, 2019
Towards a classification of stem cellsLucie Laplane, Eric Solary
Haematologica|March 25, 2018
Does being overweight contribute to longer survival rates in myelodysplastic syndrome?Eric Solary, Michaela Fontenay
La Revue Du Praticien|March 24, 2011
[Myelodysplastic syndromes]Eric Solary, Michaëla Fontenay
Journal of Leukocyte Biology|May 1, 2010
Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebratesNathalie Droin, Eric Solary
Current Hematologic Malignancy Reports|August 22, 2014
Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practiceDorothée Selimoglu-Buet, Eric Solary
Nature Genetics|March 28, 2008
Re-examining the role of cytochrome c in cell deathEric Solary, Fabrizio Giordanetto, Guido Kroemer
Cancer Discovery|April 4, 2024
Targeting Senescence for Next-Generation Cancer TreatmentsEric Gilson, Pierre Soubeyran, Eric Solary
Pageof 28